132 related articles for article (PubMed ID: 6501320)
1. Structural features required for the reactivity and intracellular transport of bis(3,5-dibromosalicyl)fumarate and related anti-sickling compounds that modify hemoglobin S at the 2,3-diphosphoglycerate binding site.
Chatterjee R; Iwai Y; Walder RY; Walder JA
J Biol Chem; 1984 Dec; 259(23):14863-73. PubMed ID: 6501320
[TBL] [Abstract][Full Text] [Related]
2. The effect of 2,3-diphosphoglycerate on the solubility of deoxyhemoglobin S.
Poillon WN; Kim BC; Welty EV; Walder JA
Arch Biochem Biophys; 1986 Sep; 249(2):301-5. PubMed ID: 3753004
[TBL] [Abstract][Full Text] [Related]
3. Methyl acetyl phosphate, a new type of antisickling agent: site-specific acetylating agent toward the 2,3-DPG binding site in hemoglobin S.
Ueno H; Manning JM
Am J Pediatr Hematol Oncol; 1988; 10(4):348-50. PubMed ID: 3239714
[TBL] [Abstract][Full Text] [Related]
4. Diaspirins that cross-link beta chains of hemoglobin: bis(3,5-dibromosalicyl) succinate and bis(3,5-dibromosalicyl) fumarate.
Walder JA; Zaugg RH; Walder RY; Steele JM; Klotz IM
Biochemistry; 1979 Oct; 18(20):4265-70. PubMed ID: 486423
[TBL] [Abstract][Full Text] [Related]
5. Thermal stability of hemoglobin crosslinked in the T-state by bis(3,5-dibromosalicyl) fumarate.
Yang T; Olsen KW
Biochem Biophys Res Commun; 1991 Jan; 174(2):518-23. PubMed ID: 1993051
[TBL] [Abstract][Full Text] [Related]
6. Formation of cross-linked asymmetrical hybrid hemoglobins by double-headed aspirin.
Kikugawa K; Adachi K; Kosugi H; Asakura T
Hemoglobin; 1983; 7(6):533-53. PubMed ID: 6668187
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha 1----lysine 99 alpha 2).
Chatterjee R; Welty EV; Walder RY; Pruitt SL; Rogers PH; Arnone A; Walder JA
J Biol Chem; 1986 Jul; 261(21):9929-37. PubMed ID: 3090027
[TBL] [Abstract][Full Text] [Related]
8. 2,3-Diphosphoglycerate and intracellular pH as interdependent determinants of the physiologic solubility of deoxyhemoglobin S.
Poillon WN; Kim BC
Blood; 1990 Sep; 76(5):1028-36. PubMed ID: 2393711
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the gelation of extracellular and intracellular hemoglobin S by selective acetylation with methyl acetyl phosphate.
Ueno H; Benjamin LJ; Pospischil MA; Manning JM
Biochemistry; 1987 Jun; 26(11):3125-9. PubMed ID: 3607016
[TBL] [Abstract][Full Text] [Related]
10. Effect of FS (alpha 2 gamma beta s) hybrid hemoglobin on Hb S nucleation and aggregation.
Nibu K; Adachi K
Biochim Biophys Acta; 1985 May; 829(1):97-102. PubMed ID: 2581620
[TBL] [Abstract][Full Text] [Related]
11. Equilibrium oxygen binding to human hemoglobin cross-linked between the alpha chains by bis(3,5-dibromosalicyl) fumarate.
Vandegriff KD; Medina F; Marini MA; Winslow RM
J Biol Chem; 1989 Oct; 264(30):17824-33. PubMed ID: 2808353
[TBL] [Abstract][Full Text] [Related]
12. Mechanism for the increase in solubility of deoxyhemoglobin S due to cross-linking the beta chains between lysine-82 beta 1 and lysine-82 beta 2.
Chatterjee R; Walder RY; Arnone A; Walder JA
Biochemistry; 1982 Nov; 21(23):5901-9. PubMed ID: 6817783
[No Abstract] [Full Text] [Related]
13. The effect of crosslinking by bis(3,5-dibromosalicyl) fumarate on the autoxidation of hemoglobin.
Yang T; Olsen KW
Biochem Biophys Res Commun; 1989 Sep; 163(2):733-8. PubMed ID: 2783118
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of sickling.
Mentzer WC
Am J Pediatr Hematol Oncol; 1982; 4(3):320-7. PubMed ID: 7149171
[TBL] [Abstract][Full Text] [Related]
15. The modification of hemoglobin by a long crosslinking reagent: bis(3,5-dibromosalicyl) sebacate.
Zhang Q; Olsen KW
Biochem Biophys Res Commun; 1994 Sep; 203(3):1463-70. PubMed ID: 7945292
[TBL] [Abstract][Full Text] [Related]
16. Deoxygenated sickle hemoglobin. Modulation of its solubility by 2,3-diphosphoglycerate and other allosteric polyanions.
Poillon WN; Robinson MD; Kim BC
J Biol Chem; 1985 Nov; 260(26):13897-900. PubMed ID: 4055763
[TBL] [Abstract][Full Text] [Related]
17. Development of antisickling compounds that chemically modify hemoglobin S specifically within the 2,3-diphosphoglycerate binding site.
Walder JA; Walder RY; Arnone A
J Mol Biol; 1980 Aug; 141(2):195-216. PubMed ID: 7441751
[No Abstract] [Full Text] [Related]
18. Affinity labeling of hemoglobin with 4,4'-diisothiocyanostilbene-2,2'-disulfonate: covalent cross-linking in the 2,3-diphosphoglycerate binding site.
Kavanaugh MP; Shih DT; Jones RT
Biochemistry; 1988 Mar; 27(5):1804-8. PubMed ID: 3365425
[TBL] [Abstract][Full Text] [Related]
19. Structural specificities in acylation of hemoglobin and sickle hemoglobin by diaspirins.
Wood LE; Haney DN; Patel JR; Clare SE; Shi GY; King LC; Klotz IM
J Biol Chem; 1981 Jul; 256(13):7046-52. PubMed ID: 7240262
[TBL] [Abstract][Full Text] [Related]
20. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
Ueda Y; Bookchin RM
J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
